Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 10,913 |
|
|||||
| News | - | ||||||
| Day High | 14.6899 | Low High |
|||||
| Day Low | 14.25 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Curis Inc | CRIS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.05 | -0.34% | 14.47 | 18:42:34 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 14.44 | 14.25 | 14.6899 | 14.47 | 14.52 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 311 | 10,913 | $ 14.45 | $ 157,657 | - | 3.80 - 19.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:03:59 | 1 | $ 14.25 | USD |
Curis Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 85.99M | 5.89M | - | 10.02M | -47.41M | -8.04 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Curis News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRIS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 14.97 | 15.16 | 14.06 | 14.69 | 10,370 | -0.50 | -3.34% |
| 1 Month | 10.85 | 17.49 | 10.69 | 15.37 | 38,929 | 3.62 | 33.36% |
| 3 Months | 10.12 | 17.49 | 8.24 | 12.24 | 30,935 | 4.35 | 42.98% |
| 6 Months | 3.90 | 17.49 | 3.89 | 10.30 | 63,622 | 10.57 | 271.03% |
| 1 Year | 15.90 | 19.60 | 3.80 | 13.31 | 162,831 | -1.43 | -8.99% |
| 3 Years | 211.40 | 348.00 | 3.80 | 88.11 | 1,401,028 | -196.93 | -93.16% |
| 5 Years | 35.20 | 348.00 | 3.80 | 99.53 | 1,642,135 | -20.73 | -58.89% |
Curis Description
| Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge. |
